Wildgoose P, Jørgensen T, Komiyama Y, Nakagaki T, Pedersen A, Kisiel W
Biopharmaceuticals Division, NOVO-NORDISK A/S, Gentofte, Denmark.
Thromb Haemost. 1992 Jun 1;67(6):679-85.
Whether or not the factor VII Gla-domain is involved in the high-affinity interaction of factor VII and tissue factor via calcium-dependent interactions with surrounding phospholipids is unknown. To investigate this, we have purified the factor VII Gla-peptide (FVII-GP) from digested recombinant human factor VIIa and assessed its effect on factor VII:tissue factor interactions. FVII-GP inhibited the activation of factor X by factor VIIa in the presence of either soluble or cell surface tissue factor half-maximally at 0.5 microM and 2.7 microM, respectively. However, FVII-GP failed to inhibit the specific binding of factor VIIa to cell-surface tissue factor, and did not inhibit the ability of tissue factor to stimulate the amidolytic activity of factor VIIa. Unrelipidated tissue factor apoprotein stimulated the amidolytic activity of factor VIIa to the same extent as relipidated tissue factor apoprotein. These findings suggest that the factor VII Gla-domain does not directly interact with tissue factor, but rather is important for calcium binding and concomitant expression of other factor VII epitopes necessary for tissue factor recognition and binding. To test this hypothesis, we have prepared a monoclonal antibody against a putative factor VII epitope that participates in the interaction of factor VII with cell-surface tissue factor (peptide 195-206) and assessed its ability to bind to factor VII in the presence and absence of calcium. Binding of this monoclonal antibody (PW-4) to intact factor VIIa was calcium-dependent and could be inhibited in a dose-dependent manner by peptide 195-206.(ABSTRACT TRUNCATED AT 250 WORDS)
凝血因子VII的γ-羧基谷氨酸(Gla)结构域是否通过与周围磷脂的钙依赖性相互作用参与凝血因子VII与组织因子的高亲和力相互作用尚不清楚。为了研究这一点,我们从消化的重组人凝血因子VIIa中纯化了凝血因子VII Gla肽(FVII-GP),并评估了其对凝血因子VII:组织因子相互作用的影响。FVII-GP在存在可溶性或细胞表面组织因子的情况下,分别在0.5 microM和2.7 microM时半最大程度地抑制了凝血因子VIIa对因子X的激活。然而,FVII-GP未能抑制凝血因子VIIa与细胞表面组织因子的特异性结合,也未抑制组织因子刺激凝血因子VIIa酰胺水解活性的能力。未脂质化的组织因子载脂蛋白刺激凝血因子VIIa酰胺水解活性的程度与脂质化的组织因子载脂蛋白相同。这些发现表明,凝血因子VII的Gla结构域不直接与组织因子相互作用,而是对钙结合以及组织因子识别和结合所需的其他凝血因子VII表位的伴随表达很重要。为了验证这一假设,我们制备了一种针对假定的凝血因子VII表位的单克隆抗体,该表位参与凝血因子VII与细胞表面组织因子的相互作用(肽195-206),并评估了其在有钙和无钙情况下与凝血因子VII结合的能力。这种单克隆抗体(PW-4)与完整的凝血因子VIIa的结合是钙依赖性的,并且可以被肽195-206以剂量依赖性方式抑制。(摘要截短至250字)